Skip to content

    Osteoporosis Health Center

    Font Size

    Osteoporosis Drugs May Be Linked to Cancer Risk

    Study Shows Some Increased Risk of Esophageal Cancer From Oral Bisphosphonates
    WebMD Health News
    Reviewed by Laura J. Martin, MD

    Sept. 2, 2010 -- The long-term use of oral bisphosphonate osteoporosis drugs such as Actonel, Boniva, and Fosamax may be associated with a doubling in esophageal cancer risk, but the risk to individual users remains small, researchers say.

    Compared to people who had never taken the medications, long-term users of the bone-building drugs known as oral bisphosphonates had nearly double the risk for the rare but deadly cancer in a newly published study.

    The findings appear to contradict a separate study published early last month, which used the same data of people living in the U.K. That research failed to find a significant increase in esophageal cancer risk in users of the osteoporosis drugs.

    Oxford University epidemiologist Jane Green, PhD, who led the latest research, says more study is needed to determine if bisphosphonate use really does increase esophageal cancer risk.

    "But the risk, if it does exist, is small in absolute terms and is not something people taking these drugs should worry too much about," she tells WebMD.

    FDA Report Raises Concerns

    Concerns about a link between bisphosphonates and esophageal cancer first reached the public about a year and a half ago with the publication of an FDA report citing 23 cases of the cancer in Fosamax (alendronate) users in the U.S. between 1995 and 2008. The report cited another 31 cases of the cancer among bisphosphonate users in Europe and Japan.

    Oral bisphosphonates such as Fosamax, Boniva, and Actonel are used by millions of osteoporosis patients in the U.S. and throughout the world to prevent further bone loss.

    Reports of esophageal inflammation related to acid reflux in some users emerged soon after their introduction in the mid-1990s, which is why users are told not to take the drugs with food or while lying down.

    Both the newly published study and the one published last month used data from a nationwide medical practice research registry in the U.K. involving about 6 million people.

    The latest analysis included close to 3,000 patients with cancer of the esophagus, 2,000 patients with stomach cancer, and 10,600 patients with colorectal cancer diagnosed between 1995 and 2005.

    Each cancer case was compared with five people without cancer matched for age and sex.

    Today on WebMD

    Women working out and walking with weights
    Reduce bone loss and build stronger muscles.
    Chinese cabbage
    Calcium-rich foods to add to your diet.
    woman stretching
    Get the facts on osteoporosis.
    Porous bone
    Causes, symptoms, risk factors, and treatment.
    senior woman
    Woman holding plate of brocolli
    wrist xray
    Superfood for Bones
    mature woman
    sunlight in hands
    man and woman in front of xray
    woman with dumbbells